The role of microenvironment and immunity in drug response in leukemia
Open Access
- 1 March 2016
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1863 (3), 414-426
- https://doi.org/10.1016/j.bbamcr.2015.08.003
Abstract
No abstract availableKeywords
Funding Information
- Universities of King Saud, Manchester and Salford
This publication has 161 references indexed in Scilit:
- Protein Kinase C-β-Dependent Activation of NF-κB in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B Cells In VivoCancer Cell, 2013
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitorsNature, 2012
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METNature Medicine, 2012
- The tumor microenvironment is a dominant force in multidrug resistanceDrug Resistance Updates, 2012
- Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4Leukemia, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Immunity, Inflammation, and CancerCell, 2010
- The Tumor Microenvironment: The Making of a ParadigmCancer Microenvironment, 2009
- Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early–intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximabLeukemia Research, 2008
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004